Integrated development services in the Quotient Sciences Translational Pharmaceutics® platform let you eliminate development bottlenecks caused by vendor complexity. Find out how it works.
One-size CDMOs fail complex injectables. Discover how tailored fill-finish cuts risk, accelerates timelines, and safeguards your product from vial to patient.
Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development and manufacturing organization (CDMO) and clinical services partner. Thermo Fisher’s end-to-end, integrated CDMO capabilities help companies on their drug development and manufacturing journeys. From research and development to regulatory landscape support, supply chain management, and everywhere in between, the company’s services and solutions support the entire life cycle of drug substances and drug products, from preclinical research to commercial manufacturing. Thermo Fisher knows your challenges and has developed solutions you can trust to help bring your treatment to market faster.
Abzena is the leading end-to-end bioconjugate (ADC, AOC, & RDC) & complex biologics CDMO + CRO. From discovery through commercial, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development and manufacture of new treatments for patients. Let us help move your program forward faster.
